262 related articles for article (PubMed ID: 22028615)
21. Wolf-Hirschhorn syndrome candidate 1 is involved in the cellular response to DNA damage.
Hajdu I; Ciccia A; Lewis SM; Elledge SJ
Proc Natl Acad Sci U S A; 2011 Aug; 108(32):13130-4. PubMed ID: 21788515
[TBL] [Abstract][Full Text] [Related]
22. WHSC1 monomethylates histone H1 and induces stem-cell like features in squamous cell carcinoma of the head and neck.
Saloura V; Vougiouklakis T; Bao R; Kim S; Baek S; Zewde M; Bernard B; Burkitt K; Nigam N; Izumchenko E; Dohmae N; Hamamoto R; Nakamura Y
Neoplasia; 2020 Aug; 22(8):283-293. PubMed ID: 32497898
[TBL] [Abstract][Full Text] [Related]
23. The epigenetic regulator Mll1 is required for Wnt-driven intestinal tumorigenesis and cancer stemness.
Grinat J; Heuberger J; Vidal RO; Goveas N; Kosel F; Berenguer-Llergo A; Kranz A; Wulf-Goldenberg A; Behrens D; Melcher B; Sauer S; Vieth M; Batlle E; Stewart AF; Birchmeier W
Nat Commun; 2020 Dec; 11(1):6422. PubMed ID: 33349639
[TBL] [Abstract][Full Text] [Related]
24. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
[TBL] [Abstract][Full Text] [Related]
25. Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers.
Yoshimatsu M; Toyokawa G; Hayami S; Unoki M; Tsunoda T; Field HI; Kelly JD; Neal DE; Maehara Y; Ponder BA; Nakamura Y; Hamamoto R
Int J Cancer; 2011 Feb; 128(3):562-73. PubMed ID: 20473859
[TBL] [Abstract][Full Text] [Related]
26. Wolf-Hirschhorn Syndrome Candidate 1 (whsc1) Functions as a Tumor Suppressor by Governing Cell Differentiation.
Yu C; Yao X; Zhao L; Wang P; Zhang Q; Zhao C; Yao S; Wei Y
Neoplasia; 2017 Aug; 19(8):606-616. PubMed ID: 28654864
[TBL] [Abstract][Full Text] [Related]
27. Functional characterization of the zebrafish WHSC1-related gene, a homolog of human NSD2.
Yamada-Okabe T; Imamura K; Kawaguchi N; Sakai H; Yamashita M; Matsumoto N
Biochem Biophys Res Commun; 2010 Nov; 402(2):335-9. PubMed ID: 20946879
[TBL] [Abstract][Full Text] [Related]
28. Activating transcription factor 2 promotes the progression of hepatocellular carcinoma by inducing the activation of the WHSC1-mediated TOP2A/PI3K/AKT axis.
Bao ZM; Yao D; Qian X; Zhang HG; Yang M; Guo YH; Qin L
Kaohsiung J Med Sci; 2022 Jul; 38(7):662-674. PubMed ID: 35394699
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effect of microRNA-154 targeting WHSC1 on cell proliferation of human skin squamous cell carcinoma through mediating the P53 signaling pathway.
Chen HQ; Gao D
Int J Biochem Cell Biol; 2018 Jul; 100():22-29. PubMed ID: 29727714
[TBL] [Abstract][Full Text] [Related]
30. Does Wnt/β-catenin pathway contribute to the stability of DNMT1 expression in urological cancer cell lines?
Varol N; Konac E; Bilen CY
Exp Biol Med (Maywood); 2015 May; 240(5):624-30. PubMed ID: 25349215
[TBL] [Abstract][Full Text] [Related]
31. MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents.
Shah MY; Martinez-Garcia E; Phillip JM; Chambliss AB; Popovic R; Ezponda T; Small EC; Will C; Phillip MP; Neri P; Bahlis NJ; Wirtz D; Licht JD
Oncogene; 2016 Nov; 35(45):5905-5915. PubMed ID: 27109101
[TBL] [Abstract][Full Text] [Related]
32. The NSD family of protein methyltransferases in human cancer.
Vougiouklakis T; Hamamoto R; Nakamura Y; Saloura V
Epigenomics; 2015 Aug; 7(5):863-74. PubMed ID: 25942451
[TBL] [Abstract][Full Text] [Related]
33. Multiple-myeloma-related WHSC1/MMSET isoform RE-IIBP is a histone methyltransferase with transcriptional repression activity.
Kim JY; Kee HJ; Choe NW; Kim SM; Eom GH; Baek HJ; Kook H; Kook H; Seo SB
Mol Cell Biol; 2008 Mar; 28(6):2023-34. PubMed ID: 18172012
[TBL] [Abstract][Full Text] [Related]
34. 4.1N is involved in a flotillin-1/β-catenin/Wnt pathway and suppresses cell proliferation and migration in non-small cell lung cancer cell lines.
Yang Q; Zhu M; Wang Z; Li H; Zhou W; Xiao X; Zhang B; Hu W; Liu J
Tumour Biol; 2016 Sep; 37(9):12713-12723. PubMed ID: 27448302
[TBL] [Abstract][Full Text] [Related]
35. Nemo-like kinase (NLK) inhibits the progression of NSCLC via negatively modulating WNT signaling pathway.
Lv L; Wan C; Chen B; Li M; Liu Y; Ni T; Yang Y; Liu Y; Cong X; Mao G; Xue Q
J Cell Biochem; 2014 Jan; 115(1):81-92. PubMed ID: 23904219
[TBL] [Abstract][Full Text] [Related]
36. SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance.
Wang T; Wu H; Liu S; Lei Z; Qin Z; Wen L; Liu K; Wang X; Guo Y; Liu Q; Liu L; Wang J; Lin L; Mao C; Zhu X; Xiao H; Bian X; Chen D; Xu C; Wang B
Cancer Lett; 2018 Aug; 430():11-24. PubMed ID: 29746925
[TBL] [Abstract][Full Text] [Related]
37. SET7/9 regulates cancer cell proliferation by influencing β-catenin stability.
Shen C; Wang D; Liu X; Gu B; Du Y; Wei FZ; Cao LL; Song B; Lu X; Yang Q; Zhu Q; Hou T; Li M; Wang L; Wang H; Zhao Y; Yang Y; Zhu WG
FASEB J; 2015 Oct; 29(10):4313-23. PubMed ID: 26116705
[TBL] [Abstract][Full Text] [Related]
38. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
Zhang Z; Yang Y; Zhang X
Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
[TBL] [Abstract][Full Text] [Related]
39. Histone 3 lysine-27 demethylase KDM6A coordinates with KMT2B to play an oncogenic role in NSCLC by regulating H3K4me3.
Leng X; Wang J; An N; Wang X; Sun Y; Chen Z
Oncogene; 2020 Oct; 39(41):6468-6479. PubMed ID: 32879445
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers.
Hayami S; Kelly JD; Cho HS; Yoshimatsu M; Unoki M; Tsunoda T; Field HI; Neal DE; Yamaue H; Ponder BA; Nakamura Y; Hamamoto R
Int J Cancer; 2011 Feb; 128(3):574-86. PubMed ID: 20333681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
